Bioregulator of the vitreous body of the eye.
Composition: 1 ml of sterile solution contains; 0.1±0.01 mg of CaCI2 and 10 -10-10-11 mg of protein-peptide complex.
Recommendations for use: for the prevention of destruction, vitreous detachment, vitreous hemorrhage, glaucoma.
Method of application: instill 1-2 drops of the solution on the eyelid, 3-5 times a day according to the state of health. Discontinuation of reception-after the disappearance of negative sensations in the eyes. When taking other ophthalmic drugs, the time interval between instillation of drugs and vioftan 9 should be at least 30 minutes..
Contraindications: not detected. Overdose: is excluded. The effect of habituation: is missing.
Storage conditions: in a clean, dry, sun-protected place at a temperature of +5 to +25 °C and a relative humidity of not more than 75%.
Expiration date: 18 months from the date of manufacture.
Release form: 15 ml bottle (≈300 drops).